Chair of the WHO Essential Medicines Committee |
United States |
Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Conflict of Interest in Clinical Practice Guideline Development |
United States |
Systematic Reviews and Guideline Development |
|
|
Corporate Strategies: Design, Conduct, Publication of Research |
United States |
Smoking and Tobacco |
|
|
Design, Evaluation and Implementation of a Marketing of Medicines Curriculum for Health Professionals |
United States |
UCSF Professional Education |
|
|
Development of Smoking Restrictions on Airlines |
United States |
Occupational and Environmental Disease, Smoking and Tobacco |
|
|
Improving Medicines Use for Noncommunicable Diseases in Low Resource Settings |
Australia |
Pharmacology and Drug Treatment, Access or Barriers to Care, Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Management Decisions in Financial Conflicts of Interest |
United States |
Systematic Reviews and Guideline Development |
|
|
Measuring Design, Reporting and Funding Bias in Nonclinical Research |
United States |
Systematic Reviews and Guideline Development, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education |
|
|
Public Attitudes About Financial Ties of Researchers |
United States |
|
|
|
Qualitative Study of Editorial Decision-Making |
United Kingdom; United States |
Health Economics and Effectiveness, Systematic Reviews and Guideline Development |
|
|
Searching for Unpublished Trials Using Trials Registers and Trials Web Sites and Obtaining Unpublished Trial Data and Corresponding Trial Protocols From Regulatory Agencies |
United States |
Systematic Reviews and Guideline Development |
|
|